byiShook Opinion
Sep 23, 2024 - 13:05
AstraZeneca stock slumped Monday after its Daiichi Sankyo-partnered drug missed its mark in a study of patients with breast cancer. The post AstraZeneca Stock Dips On Surprise Miss For Gilead-Rivaling Cancer Drug appeared first on Investor's Business Daily.
AstraZeneca stock slumped Monday after its Daiichi Sankyo-partnered drug missed its mark in a study of patients with breast cancer.
The post AstraZeneca Stock Dips On Surprise Miss For Gilead-Rivaling Cancer Drug appeared first on Investor's Business Daily.